# Lijiang Biotechnology starts construction of blood perfusion device plant

Lijiang Biotechnology held a groundbreaking ceremony for a disposable blood perfusion device project in Weixian, Hebei, China. The project has a planned investment of 200 million RMB and is expected to be completed in 2021, with an annual capacity of 1 million devices.

- Type: New facility
- Announced: 2019-02-25
- Where: Weixian, Hebei, China
- Value: $29.8M (200.0M CNY)
- Starts operating: 2021
- Status: under construction
- Capacity: 1 million disposable blood perfusion devices per year
- Products: disposable blood perfusion devices
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Lijiang Biotechnology](https://endata.com/companies/37944.md)

## Sources

- [en.hebeilijiang.com](http://en.hebeilijiang.com/news/82.html), 2019-03-12: "The commencement and completion of this project will undoubtedly usher in a new chapter in our company's development"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.